Division of Cell Matrix and Regenerative Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.
Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, Via Morego 30, 16163, Genova, Italy.
Sci Rep. 2019 Jul 19;9(1):10478. doi: 10.1038/s41598-019-46571-4.
The rapid vascularisation of biomaterials and artificial tissues is a key determinant for their in vivo viability and ultimately for their integration in a host; therefore promoting angiogenesis and maintaining the newly formed vascular beds has become a major goal of tissue engineering. The arteriovenous loop (AVL) has been an extensively studied platform which integrates microsurgery with cells scaffolds and growth factors to form neotissues. Most AVL studies to date are limited to larger animal models, which are surgically easier to perform, but have inherent limits for the understanding and interrogation of the underlying in vivo mechanisms due the paucity of transgenic models. Here, we demonstrate for the first time in a mouse model the utility of the AVL in the de novo production of vascularized tissue. We also present the combined use of the model with 3D printed chambers, which allow us to dictate size and shape of the tissues formed. This novel platform will allow for an understanding of the fundamental mechanisms involved in tissue generation de novo.
生物材料和人工组织的快速血管化是其体内存活的关键决定因素,最终也是其在宿主中整合的关键决定因素;因此,促进血管生成和维持新形成的血管床已成为组织工程的主要目标。动静脉环(AVL)是一个经过广泛研究的平台,它将微创手术与细胞支架和生长因子结合起来形成新组织。迄今为止,大多数 AVL 研究仅限于更大的动物模型,这些模型在手术上更容易进行,但由于缺乏转基因模型,对于理解和探究潜在的体内机制存在固有限制。在这里,我们首次在小鼠模型中证明了 AVL 在新血管组织生成中的实用性。我们还展示了该模型与 3D 打印室的联合使用,这使我们能够控制形成的组织的大小和形状。这个新平台将使我们能够理解新组织生成中涉及的基本机制。